1,2-dimethylhydrazine multiple interactions ISO RGD:736524 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of HMGB2 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:736524 6480464 1, 2-Dimethylhydrazine results in increased expression of HMGB2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:736524 6480464 Ethinyl Estradiol affects the expression of HMGB2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HMGB2 mRNA CTD PMID:16174780 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of HMGB2 mRNA CTD PMID:15834898 17alpha-ethynylestradiol multiple interactions ISO RGD:736524 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HMGB2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:736524 6480464 Ethinyl Estradiol results in increased expression of HMGB2 mRNA CTD PMID:16174780 , PMID:17942748 17beta-estradiol decreases expression ISO RGD:1605728 6480464 Estradiol results in decreased expression of HMGB2 mRNA CTD PMID:23019147 , PMID:31614463 17beta-estradiol increases expression ISO RGD:1605728 6480464 Estradiol results in increased expression of HMGB2 mRNA CTD PMID:16474171 , PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:736524 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:736524 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736524 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HMGB2 mRNA more ... CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HMGB2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HMGB2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HMGB2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736524 6480464 Tetrachlorodibenzodioxin results in increased expression of HMGB2 mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1605728 6480464 Tetrachlorodibenzodioxin results in decreased expression of HMGB2 mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736524 6480464 Tetrachlorodibenzodioxin affects the expression of HMGB2 mRNA CTD PMID:21570461 more ... 2-hydroxypropanoic acid increases expression ISO RGD:1605728 6480464 Lactic Acid results in increased expression of HMGB2 mRNA CTD PMID:30851411 2-methoxyethanol decreases expression EXP 6480464 methyl cellosolve results in decreased expression of HMGB2 mRNA CTD PMID:19643169 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of HMGB2 mRNA CTD PMID:15890375 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1605728 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HMGB2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMGB2 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of HMGB2 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1605728 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HMGB2 mRNA CTD PMID:28628672 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of HMGB2 mRNA CTD PMID:15890375 4-hydroxyphenyl retinamide increases expression ISO RGD:736524 6480464 Fenretinide results in increased expression of HMGB2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1605728 6480464 Decitabine affects the expression of HMGB2 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of HMGB2 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of HMGB2 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1605728 6480464 Aflatoxin B1 affects the expression of HMGB2 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1605728 6480464 Aflatoxin B1 results in decreased expression of HMGB2 mRNA CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of HMGB2 mRNA CTD PMID:15890375 alachlor increases expression EXP 6480464 alachlor results in increased expression of HMGB2 mRNA CTD PMID:12419858 all-trans-retinoic acid decreases expression ISO RGD:1605728 6480464 Tretinoin results in decreased expression of HMGB2 mRNA CTD PMID:16249480 , PMID:33167477 aminoglutethimide decreases expression ISO RGD:1605728 6480464 Aminoglutethimide results in decreased expression of HMGB2 protein CTD PMID:26102013 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of HMGB2 mRNA CTD PMID:18355885 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of HMGB2 mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HMGB2 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1605728 6480464 aristolochic acid I results in decreased expression of HMGB2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1605728 6480464 Arsenic affects the methylation of HMGB2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1605728 6480464 Arsenic affects the methylation of HMGB2 gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:736524 6480464 arsenite results in decreased expression of HMGB2 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:1605728 6480464 arsenite promotes the reaction [G3BP1 protein binds to HMGB2 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1605728 6480464 Arsenic Trioxide results in increased expression of HMGB2 mRNA CTD PMID:14703492 azathioprine decreases expression ISO RGD:1605728 6480464 Azathioprine results in decreased expression of HMGB2 mRNA CTD PMID:22623647 benzene decreases expression ISO RGD:1605728 6480464 Benzene results in decreased expression of HMGB2 mRNA CTD PMID:33064461 benzo[a]pyrene multiple interactions ISO RGD:736524 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of HMGB2 mRNA] CTD PMID:15034205 benzo[a]pyrene decreases expression ISO RGD:1605728 6480464 Benzo(a)pyrene results in decreased expression of HMGB2 mRNA CTD PMID:21632981 , PMID:21802500 benzo[a]pyrene increases expression ISO RGD:736524 6480464 Benzo(a)pyrene results in increased expression of HMGB2 mRNA CTD PMID:15034205 benzo[a]pyrene decreases expression ISO RGD:736524 6480464 Benzo(a)pyrene results in decreased expression of HMGB2 mRNA CTD PMID:17942131 benzo[b]fluoranthene increases expression ISO RGD:736524 6480464 benzo(b)fluoranthene results in increased expression of HMGB2 mRNA CTD PMID:26377693 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of HMGB2 mRNA CTD PMID:16648578 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1605728 6480464 Mustard Gas results in decreased expression of HMGB2 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:1605728 6480464 bisphenol A results in increased expression of HMGB2 mRNA CTD PMID:16474171 bisphenol A decreases expression ISO RGD:736524 6480464 bisphenol A results in decreased expression of HMGB2 mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:1605728 6480464 bisphenol A affects the expression of HMGB2 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1605728 6480464 bisphenol A results in decreased expression of HMGB2 mRNA CTD PMID:29275510 Bisphenol B increases expression ISO RGD:1605728 6480464 bisphenol B results in increased expression of HMGB2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1605728 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMGB2 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1605728 6480464 bisphenol F results in increased expression of HMGB2 protein CTD PMID:34186270 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of HMGB2 mRNA CTD PMID:24136188 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of HMGB2 mRNA CTD PMID:18636176 calcitriol multiple interactions ISO RGD:1605728 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of HMGB2 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1605728 6480464 Calcitriol results in decreased expression of HMGB2 mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:1605728 6480464 Cannabidiol results in increased expression of HMGB2 mRNA CTD PMID:27918106 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of HMGB2 mRNA CTD PMID:16278290 carbon nanotube affects expression ISO RGD:736524 6480464 Nanotubes, Carbon affects the expression of HMGB2 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:736524 6480464 Nanotubes, Carbon analog results in increased expression of HMGB2 mRNA CTD PMID:25554681 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of HMGB2 mRNA CTD PMID:19395590 choline multiple interactions ISO RGD:736524 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HMGB2 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:736524 6480464 chromium hexavalent ion affects the expression of HMGB2 mRNA CTD PMID:28472532 cisplatin affects expression ISO RGD:1605728 6480464 Cisplatin affects the expression of HMGB2 mRNA CTD PMID:23300844 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of HMGB2 mRNA CTD PMID:18355885 clozapine increases expression ISO RGD:1605728 6480464 Clozapine results in increased expression of HMGB2 protein CTD PMID:34122009 copper atom multiple interactions ISO RGD:1605728 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HMGB2 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of HMGB2 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1605728 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HMGB2 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of HMGB2 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1605728 6480464 Copper Sulfate results in decreased expression of HMGB2 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of HMGB2 mRNA CTD PMID:15755911 coumestrol multiple interactions ISO RGD:1605728 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 coumestrol increases expression ISO RGD:1605728 6480464 Coumestrol results in increased expression of HMGB2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1605728 6480464 Asbestos, Crocidolite results in increased expression of HMGB2 mRNA CTD PMID:29523930 CU-O LINKAGE decreases expression ISO RGD:1605728 6480464 cupric oxide results in decreased expression of HMGB2 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of HMGB2 mRNA CTD PMID:26577399 cyclosporin A affects expression ISO RGD:1605728 6480464 Cyclosporine affects the expression of HMGB2 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1605728 6480464 Cyclosporine results in increased expression of HMGB2 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1605728 6480464 Cyclosporine results in decreased expression of HMGB2 mRNA CTD PMID:21632981 , PMID:25562108 cyclosporin A decreases expression ISO RGD:736524 6480464 Cyclosporine results in decreased expression of HMGB2 mRNA CTD PMID:17942131 , PMID:19770486 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of HMGB2 mRNA CTD PMID:14618091 dexamethasone multiple interactions ISO RGD:1605728 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of HMGB2 mRNA more ... CTD PMID:26424790 , PMID:28628672 diarsenic trioxide increases expression ISO RGD:1605728 6480464 Arsenic Trioxide results in increased expression of HMGB2 mRNA CTD PMID:14703492 dibenz[a,h]anthracene increases expression ISO RGD:736524 6480464 1 more ... CTD PMID:26377693 dicrotophos decreases expression ISO RGD:1605728 6480464 dicrotophos results in decreased expression of HMGB2 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of HMGB2 mRNA CTD PMID:15890375 doxorubicin affects response to substance ISO RGD:1605728 6480464 HMGB2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin affects expression ISO RGD:1605728 6480464 Doxorubicin affects the expression of HMGB2 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:1605728 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1605728 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HMGB2 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:736524 6480464 epoxiconazole results in decreased expression of HMGB2 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of HMGB2 mRNA CTD PMID:15353170 finasteride increases expression EXP 6480464 Finasteride results in increased expression of HMGB2 mRNA CTD PMID:24136188 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of HMGB2 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:736524 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HMGB2 mRNA more ... CTD PMID:20938992 , PMID:22206623 folic acid multiple interactions ISO RGD:1605728 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of HMGB2 mRNA CTD PMID:24657277 furan increases expression EXP 6480464 furan results in increased expression of HMGB2 mRNA CTD PMID:20124500 genistein increases expression ISO RGD:1605728 6480464 Genistein results in increased expression of HMGB2 mRNA CTD PMID:16474171 genistein decreases expression EXP 6480464 Genistein results in decreased expression of HMGB2 mRNA CTD PMID:12075121 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HMGB2 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of HMGB2 mRNA CTD PMID:33387578 geraniol decreases expression ISO RGD:1605728 6480464 geraniol results in decreased expression of HMGB2 mRNA CTD PMID:27683099 glycerol 2-phosphate multiple interactions ISO RGD:1605728 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of HMGB2 mRNA CTD PMID:26424790 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of HMGB2 mRNA CTD PMID:24395379 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of HMGB2 mRNA CTD PMID:26391144 gold atom decreases expression ISO RGD:1605728 6480464 Gold results in decreased expression of HMGB2 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1605728 6480464 Gold results in decreased expression of HMGB2 mRNA CTD PMID:25523186 hydrogen peroxide affects expression ISO RGD:1605728 6480464 Hydrogen Peroxide affects the expression of HMGB2 mRNA CTD PMID:21179406 hydroquinone decreases expression ISO RGD:1605728 6480464 hydroquinone results in decreased expression of HMGB2 mRNA CTD PMID:23416264 imipramine affects expression EXP 6480464 Imipramine affects the expression of HMGB2 mRNA CTD PMID:18355885 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of HMGB2 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:1605728 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HMGB2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMGB2 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1605728 6480464 Ivermectin results in decreased expression of HMGB2 protein CTD PMID:32959892 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of HMGB2 mRNA CTD PMID:18355885 L-ascorbic acid multiple interactions ISO RGD:1605728 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of HMGB2 mRNA CTD PMID:26424790 L-methionine multiple interactions ISO RGD:736524 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HMGB2 mRNA CTD PMID:20938992 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of HMGB2 mRNA CTD PMID:24136188 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of HMGB2 mRNA CTD PMID:24136188 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of HMGB2 mRNA CTD PMID:35283115 lucanthone decreases expression ISO RGD:1605728 6480464 Lucanthone results in decreased expression of HMGB2 mRNA CTD PMID:21148553 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of HMGB2 mRNA CTD PMID:15890375 methotrexate multiple interactions ISO RGD:1605728 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of HMGB2 mRNA CTD PMID:24657277 miconazole increases expression ISO RGD:736524 6480464 Miconazole results in increased expression of HMGB2 mRNA CTD PMID:27462272 Monobutylphthalate decreases expression ISO RGD:736524 6480464 monobutyl phthalate results in decreased expression of HMGB2 protein CTD PMID:20553848 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA CTD PMID:22129741 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of HMGB2 mRNA CTD PMID:16026605 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO RGD:1605728 6480464 Methylnitronitrosoguanidine results in decreased expression of HMGB2 mRNA CTD PMID:12634122 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of HMGB2 mRNA, Methylnitrosourea results in increased expression of HMGB2 protein CTD PMID:16525678 , PMID:29877212 N-nitrosodiethylamine increases expression ISO RGD:736524 6480464 Diethylnitrosamine results in increased expression of HMGB2 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:736524 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of HMGB2 mRNA] CTD PMID:17854601 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA CTD PMID:22129741 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of HMGB2 mRNA, Diethylnitrosamine results in increased expression of HMGB2 protein CTD PMID:19041683 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of HMGB2 mRNA CTD PMID:15890375 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of HMGB2 mRNA CTD PMID:24136188 nitrosobis(2-oxopropyl)amine increases expression EXP 6480464 nitrosobis(2-oxopropyl)amine results in increased expression of HMGB2 protein CTD PMID:29877212 ochratoxin A decreases expression ISO RGD:1605728 6480464 ochratoxin A results in decreased expression of HMGB2 mRNA CTD PMID:22124623 ozone increases expression ISO RGD:736524 6480464 Ozone results in increased expression of HMGB2 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:736524 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HMGB2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HMGB2 mRNA CTD PMID:34911549 palbociclib decreases expression ISO RGD:1605728 6480464 palbociclib results in decreased expression of HMGB2 mRNA CTD PMID:22869556 paracetamol decreases expression ISO RGD:736524 6480464 Acetaminophen results in decreased expression of HMGB2 mRNA CTD PMID:17942131 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HMGB2 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:736524 6480464 Acetaminophen affects the expression of HMGB2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1605728 6480464 Acetaminophen results in increased expression of HMGB2 mRNA CTD PMID:21420995 paraquat increases expression ISO RGD:736524 6480464 Paraquat results in increased expression of HMGB2 mRNA CTD PMID:21463325 PCB138 multiple interactions ISO RGD:736524 6480464 [2 more ... CTD PMID:25510870 perfluorooctanoic acid decreases expression ISO RGD:1605728 6480464 perfluorooctanoic acid results in decreased expression of HMGB2 protein CTD PMID:26879310 phenobarbital increases expression ISO RGD:736524 6480464 Phenobarbital results in increased expression of HMGB2 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of HMGB2 mRNA CTD PMID:19162173 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:29877212 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of HMGB2 mRNA CTD PMID:15890375 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HMGB2 mRNA CTD PMID:12832660 more ... pirinixic acid increases expression ISO RGD:736524 6480464 pirinixic acid results in increased expression of HMGB2 mRNA CTD PMID:18301758 more ... potassium nitrate increases expression ISO RGD:1605728 6480464 potassium nitrate results in increased expression of HMGB2 mRNA CTD PMID:15878651 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of HMGB2 mRNA CTD PMID:19162173 progesterone increases expression ISO RGD:1605728 6480464 Progesterone results in increased expression of HMGB2 mRNA CTD PMID:18070364 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of HMGB2 mRNA CTD PMID:20726854 propanal decreases expression ISO RGD:1605728 6480464 propionaldehyde results in decreased expression of HMGB2 mRNA CTD PMID:26079696 quercetin decreases expression ISO RGD:1605728 6480464 Quercetin results in decreased expression of HMGB2 mRNA CTD PMID:21632981 quercitrin decreases expression ISO RGD:1605728 6480464 quercitrin results in decreased expression of HMGB2 mRNA CTD PMID:25193878 rac-lactic acid increases expression ISO RGD:1605728 6480464 Lactic Acid results in increased expression of HMGB2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1605728 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of HMGB2 mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of HMGB2 mRNA CTD PMID:19167446 , PMID:23557933 resveratrol decreases expression ISO RGD:1605728 6480464 resveratrol results in decreased expression of HMGB2 mRNA CTD PMID:15767336 rotenone increases expression EXP 6480464 Rotenone results in increased expression of HMGB2 mRNA CTD PMID:19013527 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:736524 6480464 Buthionine Sulfoximine results in increased expression of HMGB2 mRNA CTD PMID:15707499 silicon dioxide increases expression ISO RGD:736524 6480464 Silicon Dioxide results in increased expression of HMGB2 mRNA CTD PMID:29341224 sodium arsenite decreases expression ISO RGD:736524 6480464 sodium arsenite results in decreased expression of HMGB2 mRNA, sodium arsenite results in decreased expression of HMGB2 protein CTD PMID:32991915 sodium arsenite increases expression ISO RGD:1605728 6480464 sodium arsenite results in increased expression of HMGB2 protein CTD PMID:20050688 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of HMGB2 mRNA CTD PMID:22561333 succimer multiple interactions ISO RGD:736524 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGB2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1605728 6480464 Sunitinib results in decreased expression of HMGB2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:736524 6480464 Tamoxifen affects the expression of HMGB2 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1605728 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of HMGB2 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1605728 6480464 Testosterone results in decreased expression of HMGB2 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:736524 6480464 Carbon Tetrachloride results in increased expression of HMGB2 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HMGB2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:736524 6480464 titanium dioxide results in increased expression of HMGB2 mRNA CTD PMID:23557971 topotecan affects response to substance ISO RGD:1605728 6480464 HMGB2 protein affects the susceptibility to Topotecan CTD PMID:16217747 Tributyltin oxide decreases phosphorylation ISO RGD:736524 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of HMGB2 protein CTD PMID:22174045 Tributyltin oxide decreases expression ISO RGD:736524 6480464 bis(tri-n-butyltin)oxide results in decreased expression of HMGB2 mRNA CTD PMID:17942131 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of HMGB2 mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:1605728 6480464 trichostatin A affects the expression of HMGB2 mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO RGD:736524 6480464 trimellitic anhydride results in increased expression of HMGB2 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1605728 6480464 troglitazone results in decreased expression of HMGB2 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:736524 6480464 trovafloxacin results in decreased expression of HMGB2 mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:736524 6480464 Tungsten results in increased expression of HMGB2 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:1605728 6480464 Valproic Acid results in decreased expression of HMGB2 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid increases expression ISO RGD:1605728 6480464 Valproic Acid results in increased expression of HMGB2 mRNA CTD PMID:29154799 vancomycin decreases expression ISO RGD:736524 6480464 Vancomycin results in decreased expression of HMGB2 mRNA CTD PMID:18930951 vincaleukoblastine affects response to substance ISO RGD:1605728 6480464 HMGB2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of HMGB2 mRNA CTD PMID:19015723 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of HMGB2 mRNA, Zinc deficiency results in increased expression of HMGB2 protein CTD PMID:16140947 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of HMGB2 mRNA], Zinc inhibits the reaction [Zinc deficiency results in increased expression of HMGB2 protein] CTD PMID:16140947 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of HMGB2 mRNA, Zinc deficiency results in increased expression of HMGB2 protein CTD PMID:16140947 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of HMGB2 mRNA], Zinc inhibits the reaction [Zinc deficiency results in increased expression of HMGB2 protein] CTD PMID:16140947